Synthetic DNA Provider Customer & Sequence Screening

Statutory Hook: EO 14110 & HHS Guidance on Synthetic Double-Stranded DNA

Mandatory biosecurity protocols requiring commercial gene synthesis providers to verify customer identities and algorithmically screen orders for select toxin agents.

Doctrinal Framework & Legal Mechanics

Under Executive Order 14110 and Department of Health and Human Services (HHS) guidance, commercial providers of synthetic double-stranded DNA must implement comprehensive customer verification (KYC) and automated sequence screening algorithms to prevent the proliferation of select agents, regulated plant pests, and dual-use toxins.

Benchmark Precedents (1)

Leading judicial decisions governing this sub-discipline

HHS Framework for Synthetic Nucleic Acid Providers

Decided / Filed (2024)

External Benchmark Precedent

Engineering & Architecture Compliance Advisory

Integrate automated BLAST and HMMER sequence comparison engines into customer ordering portals to screen incoming oligo orders against CDC Select Agent lists prior to chemical synthesis.

Cross-Entity Knowledge Graph Matrix

Associated Doctrines:

The Daubert Gatekeeping Standard for AI & Synthetic Evidence

Codified Statutes:

Duties of Employers and Employees: General Duty Clause

Lexicon Definitions:

Volitional Conduct Requirement